Fig. 2.
Fig. 2. Kaplan-Meier actuarial disease-free survival at 14 months of the entire group of 26 patients treated with allogeneic nonmyeloablative stem cell transplantation.

Kaplan-Meier actuarial disease-free survival at 14 months of the entire group of 26 patients treated with allogeneic nonmyeloablative stem cell transplantation.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal